![Nikhil Lalwani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nikhil Lalwani
Amministratore Delegato presso
ANI PHARMACEUTICALS, INC.
Patrimonio netto: 29 M $ in data 30/06/2026
Profilo
Nikhil Lalwani is President, Chief Executive Officer & Director at ANI Pharmaceuticals, Inc. since 2020.
Formerly, Chief Executive Officer-India RX Business at Cipla Ltd. in 2020.
Chief Executive Officer at InvaGen Pharmaceuticals, Inc. from 2016 to 2020.
Chief Executive Officer at Cipla USA, Inc. from 2016 to 2020.
Associate Partner at McKinsey & Co., Inc. Education includes undergraduate studies at Georgia Institute of Technology and both undergraduate and MBA degrees from The Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/05/2026 | 349.889 ( 1,54% ) | 29 M $ | 30/06/2026 |
Posizioni attive di Nikhil Lalwani
| Società | Posizione | Inizio |
|---|---|---|
| ANI PHARMACEUTICALS, INC. | Amministratore Delegato | 08/09/2020 |
Precedenti posizioni note di Nikhil Lalwani
| Società | Posizione | Fine |
|---|---|---|
| CIPLA LIMITED | Corporate Officer/Principal | 01/08/2020 |
InvaGen Pharmaceuticals, Inc.
 InvaGen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic prescription medicines | Amministratore Delegato | 01/04/2020 |
Cipla USA, Inc.
 Cipla USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Amministratore Delegato | 01/04/2020 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Formazione di Nikhil Lalwani
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
6
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
ANI Pharmaceuticals, Inc.
 ANI Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the developing, manufacturing and marketing of generic pharmaceutical products | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Cipla Ltd.
 Cipla Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Health Technology |
Georgia Institute of Technology
 Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InvaGen Pharmaceuticals, Inc.
InvaGen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic prescription medicines | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cipla USA, Inc.
Cipla USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
